Gilead Transfers Trodelvy Asian Rights to Everest Medicines for USD280m
US pharmaceutical major Gilead Sciences Inc. (NASDAQ: GILD) today announced an agreement with Everest Medicines...
Deals
ESR Group Enters Life Sciences with Zhangjiang NEO Acquisition
Hong Kong-based real estate asset manager ESR Group Ltd (HKG: 1821) has made its first...
ClouDr Partners with Ipsen to Expand Diphereline’s Reach in China
Hangzhou Kang Ming Information Technology Co., Ltd (HKG: 9955), known as “ClouDr,” has partnered with...
E-Health Now Raises Funds for Oncology and Cardiovascular Digital Health Products
E-Health Now, a Beijing-based commercial insurance-focused health management service solutions provider, has raised an undisclosed...
KingYee and XINSEC IOT Form Strategic Partnership for Smart Ward Solutions
Shanghai-based KingYee, a leading domestic intelligent medical technology and service provider, has entered into a...
Bennu Biotherapeutics Raises Over RMB100m in Angel+ Round for Global Pipeline Development
Shanghai-based cell therapy specialist Bennu Biotherapeutics has raised over RMB100 million (USD14.8 million) in an...
Longwood Valley Medtech Partners with J&J MedTech on Digital Surgery Biosystem
Beijing-based Longwood Valley Medtech has entered into an in-depth partnership with US major Johnson &...
Elite Pharma Raises RMB100m in Series B Financing for Drug Delivery Tech
Shanghai-based Elite Pharmaceutical Technology Inc. has reportedly raised nearly RMB100 million (USD14.8 million) in a...
WuXi ATU Licenses TESSA Technology to Janssen Biotech for AAV Production
WuXi Advanced Therapies (WuXi ATU), the gene and cell therapy-focused CTDMO unit of WuXi Apptec,...
Medlander Medical Technology’s IPO Raises RMB 1 billion on Shanghai’s STAR Board
Medlander Medical Technology Inc., a leading Chinese manufacturer of pelvic floor rehabilitation equipment, has completed...
TianShiWei Raises Tens of Millions in Series A for Medical Aesthetics Expansion
hina-based Wuhan TianShiWei Biotechnology Co., Ltd has reportedly raised tens of millions of renminbi in...
BeiGene Partners with Jilin Cancer Hospital for Cancer Drug Development
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has entered into a clinical study partnership...
ByteDance Acquires Amcare Healthcare for USD1.5b via Xiaohe Health Unit
ByteDance Ltd, the parent company of social media platforms TikTok and Douyin, has acquired Amcare...
Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center
The 2022 Taihu Bay Future Healthcare Conference was held in Wuxi City, Jiangsu province, China,...
United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion
Shanghai-based United Imaging Healthcare (UIH) has completed an initial public offering (IPO) of 100 million...
Trautec Medical Raises RMB200m in Series A Financing for Recombinant Collagen R&D
China-based Jiangsu Trautec Medical Technology Co., Ltd. has reportedly raised nearly RMB200 million (USD205.3 million)...
Insilico Medicine Closes USD95m Series D Financing to Advance AI Drug Discovery
Insilico Medicine, a Hong Kong-based artificial intelligence (AI)-driven drug discovery company, announced the closure of...
Huadong Medicine to Acquire 60% Stake in Wuhu Huaren for RMB 396 Million
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that its subsidiary, Hangzhou Zhongmei Huadong Pharmaceutical...
Everest Medicines’ Xerava NDA Accepted by Taiwan’s TFDA
Everest Medicines (HKG: 1952) announced that its New Drug Application (NDA) for Xerava (eravacycline) for...
Hansoh Pharma Licenses TiumBio’s TU2670 for Endometriosis Treatment in Greater China
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) announced a licensing agreement with South Korea’s...